Press "Enter" to skip to content

Bosch Healthcare Solutions GmbH | SARS-CoV-2: Bosch PCR exams detect virus regardless of mutation

Tests additionally detect the mutant variants that first appeared within the UK and South Africa

SARS-CoV-2 detection of the Vivalytic exams from Bosch Healthcare Solutions GmbH isn’t affected by the mutations that have been first recognized within the UK and South Africa (VOC 202012/01, B.1.1.7.; 501Y.V2, B.1.351). As the exams detect the virus by amplifying goal sequences inside the viral genetic materials that aren’t influenced by the mutations current within the new strains, it is vitally unlikely that check efficiency will probably be impaired. This applies to the VRI multiplex check developed in collaboration with Randox Laboratories Ltd. in addition to to the SARS-CoV-2 speedy check. The latter is a joint growth with R-Biopharm AG which, as a singleplex speedy check, delivers a outcome on constructive samples in lower than 30 minutes and will also be used for pooling.

Contact:
Thomas Berroth
Marketing & Communication
Thomas.berroth2@de.bosch.com
+49 (0) 711 811-45 599

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: